Form 10-K/A No. 2

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-K/A No. 2

 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the fiscal year ended June 30, 2010

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE TRANSITION PERIOD FROM              TO             .

Commission File Number 000-14942

 

 

PRO-DEX, INC.

(Exact name of registrant as specified in its charter)

 

Colorado   84-1261240

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

2361 McGaw Avenue, Irvine, California 92614

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number: (949) 769-3200

Securities registered under Section 12(b) of the Exchange Act:

 

Title of each class   Name of each exchange on which registered
Common Stock, no par value   NASDAQ Capital Market

Securities registered under Section 12(g) of the Exchange Act: None.

 

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ¨    No  x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act.    Yes  ¨    No  x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No  ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained in this Form 10-K, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   ¨    Smaller reporting company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the closing sales price on the Nasdaq Capital Market of such common equity on December 31, 2009: $3,553,022 . For the purpose of this calculation, shares owned by officers, directors and 10% stockholders known to the registrant have been deemed to be owned by affiliates. This determination of affiliate status is not a determination for other purposes.

The number of shares outstanding of each of the issuer’s classes of common stock outstanding as of the latest practicable date: 3,251,850 shares of common stock, no par value, as of September 23, 2010.

 

 

DOCUMENTS INCORPORATED BY REFERENCE: Part III incorporates by reference certain information from the registrant’s definitive proxy statement (the “Proxy Statement”) for the 2010 Annual Meeting of Shareholders.

 

 

 


EXPLANATORY NOTE

On September 28, 2010, Pro-Dex, Inc. (the “Company) filed its Annual Report on Form 10-K for the year ended June 30, 2010 with the Securities and Exchange Commission. On May 6, 2011, the Company filed Form 10-K/A No. 1 with the Securities and Exchange Commission to amend the aforementioned Annual Report on Form 10-K for the following:

 

   

In Item 9A of the Form 10-K, the conclusions of the Company’s principal executive and principal financial officers regarding the effectiveness of the Company’s disclosure controls and procedures were made “for the quarter ended June 30, 2010,” rather than “as of June 30, 2010” as required by Item 307 of Regulation S-K. In the Form 10-K/A No. 1, the effective period covered by the conclusions regarding the Company’s controls, as described above, has been corrected.

 

   

In the Form 10-K, the Company inadvertently failed to include the conformed signature of its independent registered accounting firm on both the Report of Independent Accounting Firm and Exhibit 23.1. In the Form 10-K/A No. 1, the conformed signature of the independent registered accounting firm has been included on both the Report of Independent Accounting Firm and Exhibit 23.1

 

   

The last paragraph of the Report of Independent Accounting Firm included in the Form 10-K contained a typographical error in that it referred to “each of the two years in the two-year period ended June 30, 2010,” rather than referring to “each of the years in the two-year period ended June 30, 2010” as required by Item 302(a) of Regulation S-T. In the Form 10-K/A No. 1, this typographical error has been corrected.

 

   

In Item 7 and in Note 2 to Notes to Consolidated Financial Statements in the Form 10-K, the Company described its accounting policy for recording owned land and buildings as “at the value of their best and highest use.” In the Form 10-K/A No. 1, the description of this policy has been clarified to indicate that “property, plant, equipment and leasehold improvements is recorded at historical cost.”

 

   

In Exhibits 31.1 and 31.2 to the Form 10-K, certain wording was not in conformity with the requirements of Exchange Act Rule 13a-14(a). In the Form 10-K/A No. 1, such wording has been corrected.

This Form 10-K/A No. 2 is being filed to amend the aforementioned Form 10-K, as amended by Form 10-K/A No. 1, for the following:

 

   

The complete text of each of the Items in the aforementioned Annual Report on Form 10-K that were affected by the changes described above in connection with the Company’s filing of the Form 10-K/A No. 1 has been provided in this Form 10-K/A No. 2 in conformity with Item 307 of Regulation S-K.

 

   

The Statement of Operations for the year ended June 30, 2010 in the aforementioned Annual Report on Form 10-K contained an item captioned “Impairment of intangible assets,” in which were included the aggregate charges for impairment of goodwill and patent. In this Form 10-K/A No. 2, the impairment for goodwill has been segregated from the impairment of patent in the Statement of Operations, in conformity with ASC 350-20-45-2.

 

   

Note 2 of Notes to Consolidated Financial Statements in the Form 10-K has been expanded to disclose the Company’s accounting policy for research and development costs, which is to charge such costs to expense as incurred.

Other than the changes described in this Explanatory Note, the Company is not amending or updating any information contained within its Annual Report on Form 10-K for the year ended June 30, 2010 (the “Initial Filing”).

Therefore, this Form 10-K/A No. 2 should be read in conjunction with the Company’s other filings made with the Securities and Exchange Commission subsequent to the date of the Initial Filing.

 

2


Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of the Company’s results of operations and financial condition for each of the two years ended June 30, 2010 and 2009, respectively. This discussion should be read in conjunction with the Consolidated Financial Statements and the Notes thereto included elsewhere in this report. This report contains certain forward-looking statements and information. The cautionary statements included below and elsewhere in this report should be read as being applicable to all related forward-looking statements wherever they may appear. Our actual future results could differ materially from those discussed herein.

Critical Accounting Estimates and Judgments

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. The significant accounting policies that are believed to be the most critical to fully understanding and evaluating our reported financial results include revenue recognition, warranty reserve, inventory valuations for slow moving items, impairment of goodwill, and the recovery of deferred income tax assets.

Revenue Recognition

Revenue on virtually all product sales is recognized upon shipment to the customer based on its terms of FOB shipping point, where the risk of loss and title transfer to the customer. We record sales in accordance with ASC 605 (formerly Staff Accounting Bulletin No. 104, Revenue Recognition). Under these guidelines, revenue is recognized when all of the following are satisfied: persuasive evidence that a sale arrangement exists, delivery of the product has occurred, the price is fixed or determinable, and payment is reasonably assured. We sell some of our products with a warranty that provides for repairs or replacement of any defective parts for a period after the sale. At the time of the sale, the Company accrues an estimate of the cost of providing the warranty based on prior experience. The Company recognizes revenue under research and development agreements as certain deliverables are met as specified in each development contract.

There have been minimal returns for credit, so no reserve for product returns has been established.

Inventory

We determine our inventory value at the lower of cost (first-in, first-out method) or market value. We determine a reduced market value of our inventory based on the aging of inventory on hand. We define “aging of inventory” as inventory that exceeds an estimated 12 months of usage and exceeds orders on hand.

Accounts Receivable

We determine the reserve for our accounts receivable by examining the aging of receivables. We define “aging of receivables” as time passed since (i) the sale was completed, (ii) revenue was recognized and (iii) the receivable was established. If the receivable is aged over 90 days old, or has a known collection risk, it is reserved from anywhere between 10% of its value up to 100% of its value depending on account credit and collection history.

Goodwill

In accordance with ASC 350 (formerly SFAS No. 142, “Intangible—Goodwill and Other”) intangible assets with definite lives are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit and adverse legal or regulatory developments. We assess potential impairment of our goodwill and intangible assets when there is evidence that recent events or changes in circumstances have made recovery of an asset’s carrying value unlikely. We also assess potential impairment of our goodwill and intangible assets on an annual basis during our fiscal fourth quarter, regardless if there is evidence or suspicion of impairment.

If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flow over the remaining amortization periods, the carrying values are reduced to estimated fair market value. In accordance with ASC 350, a two-step impairment test is required to identify potential goodwill impairment and measure the amount of the goodwill impairment loss to be recognized. In the first step, the fair value of each reporting unit is compared to its

 

3


carrying value to determine if the goodwill is impaired. If the fair value of the reporting unit exceeds the carrying value of the net assets assigned to that unit, then goodwill is not impaired and no further testing is required. If the carrying value of the net assets assigned to the reporting unit exceeds its fair value, then the second step is performed in order to determine the implied fair value of the reporting unit’s goodwill and an impairment loss is recorded for an amount equal to the difference between the implied fair value and the carrying value of the goodwill.

Determining the fair value of a reporting unit (an intangible asset) is judgmental and involves the use of significant estimates and assumptions. We base our fair value estimates on assumptions that we believe are reasonable but are uncertain and subject to changes in market conditions. For the purposes of identifying and measuring impairment, goodwill assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flow of other assets and liabilities.

We identify two reporting units for purposes of our annual goodwill impairment testing arising from our acquisitions of Micro Motors and Astromec

 

   

Our Carson City reporting unit corresponds to the operations resulting from the Astromec acquisition,

 

   

Our Irvine reporting unit corresponds to the operations resulting from the Micro Motors acquisition.

In determining if a triggering event has occurred, we consider not only expectations for growth in the entire US economy, but also expectations for regional growth specific to our sales markets and specific to our industry and product lines. While our operating units are influenced by changes in the general economic outlook of the United States, they are most heavily influenced by changes specific to the medical device industry. Furthermore, the magnitude of economic changes within the industry is viewed alongside the outlooks and forecasts specific to the reporting units to obtain a better sense of the likelihood that goodwill may be impaired. Declines within the industry’s outlook are reflected in the unit’s revenue projections.

During the preparation of the fiscal year 2010 financial statements, we determined a triggering event occurred for Micro Motors as new and replacement revenue sources for a potential loss of our largest customer had not been completed. During the preparation of the fiscal year 2010 financial statements we also determined a triggering event for Astromec as it became apparent that the expected product synergies and resulting financial benefits from the 2006 Astromec acquisition were not being realized. (See Note 10 of the consolidated financial statements).

In estimating the fair value of the reporting units, we considered the two traditional approaches to valuation, the market approach and the income (discounted cash flow “DCF”) approach. The market approach compares the subject company with guideline publicly-traded companies. Valuation multiples are calculated from the selected companies to provide an indication of how much a current investor in the marketplace would be willing to pay for a company with similar characteristics. The income approach measures the projected cash flows expected to be realized from the asset. The value of a business is the expected cash flows discounted to a present value at a discount rate that considers the degree of risk associated with the realization of the projected monetary benefits. The cash flow analysis relies upon estimates of the entity’s future revenue and expenses to ultimately project the future cash flows resulting from the business activity of each entity. An appropriate discount rate is reached by calculating the weighted average cost of capital, or “WACC,” which is determined by the assumptions underlying the Capital Asset Pricing Model, or “CAPM,” and is considered to reflect the view of “Market Participants,” as required under ASC 825 (formerly SFAS 157).

The material assumptions relied upon in the analyses used to value the Micro Motors and Astromec reporting units and goodwill are shown below.

Astromec

 

1) Market Approach

 

  (a) Nine public companies were identified that had a range of revenue to value multiples of between 0.19 times to a high of 1.02 times with a median revenue multiple of 0.43.

 

  (b) Eleven similar open market transactions were identified that had revenue to value multiples that ranged from a low of 0.25 to a high of 0.77 with a median revenue multiple of 0.56

 

  (c) The low multiples were used to determine the fair value due to Astromec’s small size and profitability.

 

2) Income Approach

 

  (a) A discounted cash flow model was constructed using a ten –year forecast for the reporting unit to determine a debt-free cash flow forecast. The present value of the cash flows and residual value were discounted to a present value using the WACC.

 

  1. The inputs to the CAPM to determine the cost of equity used in the WACC were:

 

  i. Risk free rate of 3.74%
  ii. Relevered Beta of 1.24

 

4


  iii. Equity risk premium of 5.18%
  iv. Small cap stock premium of 6.28%
  v. Reporting unit risk premium of 2.0%

 

  2. The reporting unit’s cost of equity was estimated to be 16.4%

 

  (b) The cost of debt was 6.05% based on Moody’s Baa seasoned bond rate.

 

  (c) Based on the debt/equity capital structure of the peer group of 83% equity and 17% debt, the WACC was estimated at 15.8%.

Micro Motors

 

1) Market Approach

 

  (a) Ten public companies were identified that had a range of revenue to value multiples of between 0.20 times to a high of 1.00 times with a median revenue multiple of 0.47.

 

  (b) Eleven similar open market transactions were identified that had revenue to value multiples that ranged from a low of 0.25 to a high of 0.77 with a median revenue multiple of 0.56

 

  (c) The mean multiples were used to determine the fair value due to Micro Motor’s size.

 

2) Income Approach

 

  (a) A discounted cash flow model was constructed using a ten–year forecast for the reporting unit to determine a debt-free cash flow forecast. The present value of the cash flows and residual value were discounted to a present value using the WACC.

 

  1. The inputs to the CAPM to determine the cost of equity used in the WACC were:

 

  i. Risk free rate of 3.74%
  ii. Relevered Beta of 0.85
  iii. Equity risk premium of 5.18%
  iv. Small cap stock premium of 6.28%

 

  2. The reporting unit’s cost of equity was estimated to be 14.4%

 

  (b) The cost of debt was 6.05% based on Moody’s Baa seasoned bond rate.

 

  (c) Based on the debt/equity capital structure of the peer group of 83% equity and 17% debt, the WACC was estimated at 12.5%.

As the fair value of the equity was below the carrying value of the equity at both Astromec and Micro Motors, the goodwill was considered impaired and a step 2 analysis was required. In the step two analysis, it was determined that all the remaining goodwill for these two reporting units was impaired. Goodwill impairment associated with Astromec recognized as an operating expense was $1,887,000. Goodwill impairment associated with Micro Motors recognized as an operating expense was $1,110,000.

Long-lived assets

In accordance with ASC 360 (formerly SFAS No. 144, “Accounting for the Impairment or Disposal for Long-Lived Assets”), we review the recoverability of our long-lived assets, such as property and equipment, when events or changes in circumstances occur that indicate the carrying value of the asset group may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of the asset or asset group from the expected future pre-tax cash flows, undiscounted and without interest charges, of the related operations. If these cash flows are less than the carrying value of such assets, an impairment loss is recognized for the difference between estimated fair value and carrying value. The measurement of impairment requires management to estimate future cash flows and the fair value of long-lived assets.

Given the Company’s lack of a direct dental distribution channel, in fiscal year 2009 third quarter, it stopped actively promoting the intraosseous dental anesthesia delivery product (“Intraflow”) that is based on the intangible asset resulting from the purchase of certain assets from IntraVantage, Inc. in October 2005. Any substantial future value therefore is derived from the possibility that a company with a direct dental distribution channel (a “Market Participant”) might be interested in access to the technology through product purchases, licenses, acquisition, joint venture, or other means. Given the current economic environment, the general lack of investment in new products, the limited number of Market Participants to whom this technology relates, the time and expense necessary to consummate a transaction, and other factors considered by management, there is also a significant possibility that no distribution partner will be found, resulting in effectively no value of the asset. Given this change in circumstance, in accordance with ASC 360 (formerly SFAS No. 144 “Accounting for the Impairment or Disposal of Long-Lived Assets.”) management tested the

 

5


carrying amount of the intangible asset for recoverability as of March 31, 2009. The result of management’s analysis (based on several scenarios with varying probabilities of occurring) was that the asset’s value was impaired and, accordingly, a charge of $997,000 was taken in the fiscal 2009 third quarter. As market conditions have not improved and no distribution partner has been found as of December 31, 2009, management concluded that the asset’s value was further impaired and, accordingly, a charge for the remaining value of $140,000 was taken in the fiscal 2010 second quarter.

 

     Carrying Value  
     6/30/2009      Amortization     Impairment     6/30/2010  

Intangibles - Patents

   $ 147,000       $ (7,000   $ (140,000   $ —     
                                 

We determined a triggering event occurred with the Carson City land and building (“the property”) due to the expected undiscounted cash flows being below the carrying value of the property, indicating impairment. The fair value is defined pursuant to ASC 820 – Fair Value Measurements as the price that would be received in an orderly transaction between market participants at the measurement date. The fair value was estimated based on market conditions and comparable transactions.

 

     Carrying Value  
     6/30/2009     Depreciation     Impairment     6/30/2010  

Land

   $ 757,000        $ (478,000   $ 279,000   

Building

   $ 1,470,000        $ (829,000   $ 641,000   
                                

Accumulated Depreciation

   $ (122,000   $ (38,000   $ —        $ (160,000
                                

Total Land & Building, net

   $ 2,105,000      $ (38,000   $ (1,307,000   $ 760,000   
                                

Warranties

Our warranty accrual is determined by reviewing the return rates and warranty repair costs for warranty eligible products. We accrue an amount of expected repair cost based on these factors projected for the future applicable warranty period. If actual return rates or repair costs differ from our estimates, actual results could vary from the projected accrual. The repair return rates and cost assumptions are reviewed quarterly.

Property, Plant, Equipment and Leasehold Improvements, Net

Property, plant and equipment is recorded at historical cost and consists of the following:

 

     6/30/2010     6/30/2009  
     Audited     Audited  

Land

   $ 279,000     $ 757,000  

Building

   $ 641,000     $ 1,470,000  

Leasehold Improvements

   $ 2,286,000     $ 2,283,000  

Equipment

   $ 6,745,000     $ 6,620,000  
                

Total

   $ 9,951,000     $ 11,130,000  

Accumulated Depreciation

   $ (5,859,000   $ (5,149,000
                

Total property, plant & equipment, net

   $ 4,092,000     $ 5,981,000  
                

Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: building - 39 years, equipment - 3 to 10 years; and leasehold improvements are depreciated over the shorter of the term of the lease or their estimated useful lives.

As noted above, the value of the Carson City land and building was revalued to its current market value in 2010. The land was reduced to $279,000 from $757,000 and the building was reduced to $641,000 from $1,470,000.

Stock-Based Compensation

We are subject to ASC 718 (formerly SFAS No. 123 (R) Accounting for Stock-Based Compensation, as revised December 2004.) This standard establishes the accounting standards for equity compensation, and applies to us in the recognition of the cost of stock options awarded based on the grant-date fair value of those awards.

 

6


Income Taxes

As part of the process of preparing our consolidated financial statements, we are required to estimate our income taxes in each of the jurisdictions in which we operate. This process involves estimating the actual current tax liabilities together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within the consolidated balance sheet. The most significant tax assets are future deductions from the amortization of intangibles over the next ten years, inventory reserves and net operating loss carry forwards. Tax assets also result from net operating losses and research and development tax credits. We must then assess the likelihood that the deferred tax assets will be recovered from future taxable income and, to the extent we believe that recovery is not likely, a valuation allowance must be established. To the extent we establish a valuation allowance or increase or decrease this allowance in a period, the impact will be included in the tax provision in the statement of operations.

Significant management judgment is required in determining our provision for income taxes and the recoverability of our deferred tax asset. Such determination is based primarily on our historical taxable income, with some consideration given to our estimates of future taxable income by jurisdictions in which we operate and the period over which our deferred tax assets will be recoverable. We carry a valuation allowance against our deferred tax assets and changes in this allowance are reflected through income tax expense.

Year in Review

2010 proved to be a much better year for Pro-Dex following the down year for the world’s economy and Pro-Dex in fiscal year 2009. Our consolidated sales for 2010 grew by 10% as compared to 2009, bringing our five year cumulative average growth back to over 10% per year. Over a longer term, we maintained a cumulative average growth rate of almost 10% per year since fiscal year 2003.

Our medical products business resumed its growth in 2010 as sales were over 13% higher than the previous year. Strong demand from our top two customers and a new product that we delivered to one of those customers drove the sales increase. Unfortunately, as discussed elsewhere in this report, in December 2009 we received notice from our largest customer that it is working to manufacture for itself the two products that we currently produce for the customer, potentially reducing our sales to them beginning in calendar year 2011.

Our motion control business was particularly adversely affected in 2009 as our high margin products associated with this business are used by capital equipment providers, and these orders slowed substantially in our third quarter (January-March 2009). In response to the unfavorable demand environment for these products, we sensed an opportunity to gain market share in the motion control marketplace and added additional sales resources in January 2009 to aggressively uncover and pursue new customer and new sales channel opportunities. Sales levels gradually increased through the year and ended 2010 at a run rate of approximately 80% of the sales levels seen before the 2009 downturn.

Our year-end backlog of orders remained at the high end of the historical range at $11.2 million, up from $9.8 million at June 2009 and $10.4 million at June 2008.

The cost control efforts established in the prior years continued to show positive results. Our gross margin increased from 32% in 2009 to 36% of sales in 2010, a level not seen since 2006. Our reported operating costs in 2010 were $11.6 million, up from $8.3 million in 2009, but as in 2009, were clouded by non-cash impairment charges. These non-cash charges totaled over $4.4 million dollars in 2010, consisting of:

 

  (1) We wrote off the remaining $140,000 of the patent intangible in December 2010 as no strategic distribution partner was found for the product line.

 

  (2) By the end of fiscal 2010, it became apparent that the expected product synergies and resulting financial benefits from the 2006 Astromec acquisition were not being realized. As a result, we determined that the asset was impaired and wrote off $1.9 million in goodwill associated with the acquisition.

 

  (3) We also realized the decline in market value of the Carson City land and building and wrote down that asset’s value by $1.3 million.

 

  (4) In addition, due to the uncertain outlook of the medical device business related to the potential reduction in business from a major customer, the remaining $1.1 million in goodwill from the 1995 acquisition of Micro Motors was determined to be impaired and written off.

2009 included a $997,000 charge for writing down the majority of the value of the patent intangible.

Without the impairment charges, operating expenses remained stable at $7.2 million in 2010 and in 2009.

 

7


We continue to have a full allowance on our $3.0 million in deferred tax assets at the end of 2010, up from $2.1 million at the end of 2009.

Despite the reported loss, we significantly improved the Company’s financial position by generating over $3.2 million in operating cash for the 2010 fiscal year, following the $1.7 million generated in 2009 and $2.0 million in 2008. Our net debt balance of $2.2 million from 2009 turned to a net cash balance of $900 thousand as our cash balances exceeded our debt balances. The cash generated was a result of normal ongoing operations generating over $1.2 million in pre-tax profitability in 2010 before consideration of the impairments. We also benefited from a change in the tax law that allowed us to recover $547,000 in previously unavailable tax credits. We continue to have nothing borrowed on our credit line and ended the year with approximately $3.8 million in cash on hand.

RESULTS OF OPERATIONS

Results of Operations for Fiscal Year Ended June 30, 2010, Compared to Fiscal Year Ended June 30, 2009

The following table sets forth financial data and the percentage of net revenues regarding the Company’s financial position and operating results.

 

     Fiscal Year ended June 30,  

(In Thousands)

   2010      2009  

Net sales:

   $ 23,211        100    $ 21,122        100

Cost of sales

     14,847        64      14,374        68
                                 

Gross Profit

     8,364        36      6,748        32

Selling, general and administrative expenses

     4,670        20      4,452        21

Intangible and Property Value Impairment

     4,444        19      997        5

Research and development costs

     2,480        11      2,791        13
                                 

Loss from Operations

     (3,230     (14 %)       (1,492     (7 %) 

Net interest expense and net other income

     158        1      212        1

Benefit for Income Taxes

     (1,130     (5 %)       (1,100     (5 %) 

Allowance for deferred tax asset

     710        3      2,241        11
                                 

Net Loss

   $ (2,968     (13 %)     $ (2,845     (13 %) 
                                 

Net Sales. Consolidated sales increased 10% or $2,089,000 to $23,211,000 from $21,122,000 for 2010 as compared to 2009. Medical sales were higher by $2,693,000 or 24%, due to higher sales to our largest customer of $2,737,000 as that customer continues to build inventory (see Note 8 of the consolidated financial statements). Shipments to dental customers decreased by $501,000 or 19%, as we strategically reduced sales of certain low profit products. Sales to industrial customers decreased by $130,000 or 5%, reflecting a slowdown in our motion control business primarily in the first six months of fiscal year 2010. Aerospace sales were up $361,000 or 14%, due to higher commercial aircraft motor shipments. Sales related to government research related products and product repairs were down 14%, due primarily to a decline in government agency related work.

Although selective price increases and decreases were implemented in response to market conditions, the majority of the sales growth and declines for each product line is due primarily to changes in sales volume, not the effect of price changes.

The amount of Pro-Dex total sales to each customer type and the year-to-year change is noted in the table below:

 

     Fiscal Year ended
June 30,
     Increase/
(Decrease)
 

Sales by customer type ($’000)

   2010      2009     

Medical

   $ 13,800       $ 11,107         24

Aerospace

     2,985         2,624         14

Industrial

     2,318         2,448         (5 %) 

Dental

     2,119         2,620         (19 %) 

Government research and other

     1,989         2,324         (14 %) 
                          

Total Sales

   $ 23,211       $ 21,123         10
                          

 

8


Gross Profit and Gross Profit Percentage of Sales. Our consolidated gross profit for 2010 increased $1,616,000 or 24% compared to the gross profit in the previous year, due to the higher medical sales and improved Industrial sales mix. Gross profit as a percentage of sales increased to 36% for the year ended June 30, 2010 compared to 32% for the year ended June 30, 2009. Gross margin as a percentage of sales was positively impacted as a more favorable sales mix comprised mostly of the increase higher margin medical products and the decrease in lower margin dental products. Gross profit and gross profit as a percentage of sales were as follows:

 

     Fiscal Year ended June 30,        
     2010     2009     Increase  

Gross Profit

   $ 8,364,000      $ 6,748,000        24
                        

Gross Profit Percentage of Sales

     36     32  
                  

Selling, General and Administrative Costs (S, G&A). S, G & A expenses (including $4,444,000 and $997,000 intangible and property value impairment charges in 2010 and 2009 respectively) increased 67% to $9,113,000 for the year ended June 30, 2010 from $5,449,000 for year ended June 30, 2009. We had a 7% increase in selling expense mainly due to increased promotion and advertising ($56,000) and increased employee compensation ($19,000). General and administrative costs were higher by 4% due to increases in employee compensation ($134,000) offset by reduced consulting costs ($35,000).

As a percentage of sales, S, G&A costs increased to 39% from 22% for the year ended June 30, 2010 and 2009, respectively. The increase in G&A costs related to impairment was 19% and 4% for the years ended June 30, 2010 and 2009 respectively. S, G&A costs were as follows:

 

     Fiscal Year ended June 30,        
     2010     2009     Increase  

Selling

   $ 1,382,000      $ 1,295,000        7

General and administrative

   $ 3,287,000      $ 3,157,000        4

Intangible asset and property value impairment

   $ 4,444,000      $ 997,000        346
                        

Total Selling, General & Administrative cost

   $ 9,113,000      $ 5,449,000        67
                        

S, G&A Percentage of Sales

     39     22  
                  

Research and Development Costs. Research and development expenses decreased $311,000 to $2,480,000 for the year ended June 30, 2010 from $2,791,000 for the year ended June 30, 2009, a decrease of 11%. The decrease was primarily due to decreased labor and related costs. Research and development costs were as follows:

 

     Fiscal Year ended June 30,        
     2010     2009     Decrease  

Research and Development (R&D) Costs

   $ 2,480,000      $ 2,791,000        (11 %) 
                        

Research and Development costs Percentage of Sales

     11     13  
                  

Operating Loss and Operating Loss as a Percentage of Sales. Our consolidated operating loss for the year ended June 30, 2010 was $3,230,000 compared to an operating loss of $1,492,000 for the year ended June 30, 2009. Operating loss as a percentage of sales increased to 14% for the year ended June 30, 2010 compared to 7% for the year ended June 30, 2009. Operating loss and operating loss as a percentage of sales were as follows:

 

     Fiscal Year ended June 30,        
     2010     2009     (Decrease)  

Operating (Loss)

   $ (3,230,000   $ (1,492,000     116
                        

Operating (Loss) Percentage of Sales

     (14 %)      (7 %)   
                  

Royalties and Other Income. We earned and received $44,000 in royalty payments in fiscal year 2010, compared to $14,000 in royalty payments in 2009. The increase in 2010 was due to a single one-time royalty termination payment of $40,000. We had no “other” expense during the years ended June 30, 2010 and 2009

Net Interest Income/Expense. Net interest expense was $202,000 in the year ended June 30, 2010, which included $204,000 in interest expense offset by $2,000 in interest income, compared to $226,000 in the year ended June 30, 2009 which included $228,000 in interest expense offset by $2,000 in interest income.

 

9


The decrease in interest expense is due to reductions in the outstanding principal of our Carson City real estate loan and five year term note. We continue to carry no balance on our revolving credit line note.

 

     Fiscal Year ended June 30,     Increase/
(Decrease)
 
      2010     2009    

Debt related interest expense

   $ 204,000      $ 228,000        (11 %) 

Interest income

   $ (2,000   $ (2,000     0
                        

Net interest expense

   $ 202,000      $ 226,000        (11 %) 
                        

Interest expense as a Percentage of Sales

     1     1  
                  

Income Tax Provision. Our estimated effective combined federal and state tax rate on loss from operations for the year ended June 30, 2010 resulted in a 12% benefit of loss before tax compared to a 67% provision of loss before tax for the year ended June 30, 2009. The difference is due to the $2,241,000 valuation allowance against our current and long term deferred tax assets established in 2009 which resulted in a net $1,141,000 income tax provision during the fiscal year ended June 30, 2009. The valuation allowance was increased by $710,000 in 2010, which partially offset the tax benefit from the loss before tax for the year. The deferred tax valuation allowance is more fully described in Note 5 of the accompanying Consolidated Financial Statements.

As part of the process of preparing our consolidated financial statements, we are required to estimate our income taxes in each of the jurisdictions in which we operate. This process involves estimating our actual current tax liabilities together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheet. The deferred tax assets result primarily from tax basis of intangible assets in excess of book basis. Each period we must assess the likelihood that our deferred tax assets will be recovered from future taxable income and to the extent management believes that recovery is not likely, we must establish a valuation allowance. To the extent a valuation allowance is either increased or decreased in a period, the impact will be included in the tax provision in the statement of operations.

Significant management judgment is required in determining our provision for income taxes and the recoverability of our deferred tax asset. Such determination is based primarily on our historical taxable income, with some consideration given to our estimates of future taxable income by jurisdictions in which we operate and the period over which our deferred tax assets will be recoverable. Due to cumulative losses during the past three years, we maintain a $2,951,000 valuation allowance against our deferred tax assets as of June 30, 2010. Changes in the valuation allowance are recorded through income tax expense and included in the tax provision in the statement of operations.

Net (Loss) We had a net loss of $2,968,000 or $0.92 per share, basic, for the year ended June 30, 2010, compared to a net loss of $2,845,000 or $0.88 per share, basic, for the year ended June 30, 2009.

Liquidity and Capital Resources

The following table presents selected financial statistics and information for the periods indicated:

 

     As of  
     June 30, 2010      June 30, 2009  

Cash and cash equivalents

   $ 3,794,000       $ 1,124,000   
                 

Working Capital¹

   $ 6,369,000       $ 4,548,000   
                 

Credit Line outstanding balance

   $ —         $ —     
                 

Tangible book value/common share²

   $ 2.36       $ 2.27   
                 

Number of days of sales outstanding (DSO) in accounts receivable at end of quarter³

     43         41   
                 
     Year ended  
     June 30, 2010      June 30, 2009  

Net cash provided by operations

   $ 3,240,000       $ 1,718,000   
                 

 

1 

Working Capital = Ending Current Assets balance – Ending Current liabilities balance

 

2 

Tangible book value/common share = {(Total shareholders’ equity – Net intangible asset (patents) – Goodwill)}/(basic outstanding shares)

 

3 

DSO = Ending Net Accounts Receivable balance/(Previous Quarter Sales/91)

 

10


Our working capital at June 30, 2010 increased $1,821,000 (40%) to approximately $6.4 million compared to approximately $4.5 million at June 30, 2009. The increased working capital is due primarily to an increase in cash and equivalents of $2,670,000 offset by an increase in current liabilities of $1,034,000 compared to June 30, 2009. Net cash provided by operations during fiscal year 2010 was $3,240,000 as compared to $1,718,000 during fiscal year 2009. Fiscal year 2010 cash provided by operating activities was primarily the result of the net loss from operations of $2,968,000 offset by non-cash items of $5,153,000 and changes in operating assets and liabilities of $1,055,000. The non-cash items consisted primarily of depreciation and amortization of $726,000, Carson City land and building impairment of $1,307,000, Carson City goodwill impairment of $1,886,000 Micro Motors goodwill impairment of $1,110,000 and the remaining IntraFlow patent impairment of $140,000. Cash provided by changes in operating assets and liabilities was primarily due to an increase in accounts payable of $451,000, an increase in employee bonus accrual of $502,000 and an increase in warranty reserve of $168,000. Included in the operating cash is a one-time benefit from a change in the tax law that allowed us to recover $549,000 in previously unavailable tax credits.

Management believes that our working capital needs over the next twelve months can be adequately supported by current operations.

Potential Reduction in Large Customer Orders

In December, 2009 our largest customer informed us that is was in the process of developing, and planned to eventually manufacture, its own surgical hand pieces which are functionally comparable to the two products currently provided to the customer by the Company. Pro-Dex has been the exclusive manufacturer of these products since they were developed.

We currently provide the Customer with two products (“Product A” and “Product B”) and repair services for such products. Total revenue shipped in the last two fiscal years by each of these categories is as follows:

 

    

Revenues during the

12 months ended

     Average
% of
Total
 
     6/30/2010      6/30/2009     

Product A

   $ 4,398,000       $ 2,851,000         46

Product B

   $ 3,965,000       $ 2,717,000         42

Repairs

   $ 905,000       $ 962,000         12
                          
   $ 9,268,000       $ 6,530,000         100

The customer has indicated that it has successfully developed, tested, and released its version of Product A and is currently shipping such product to new accounts. The customer has also indicated that it intends to continue to purchase from Pro-Dex sufficient levels of Product A to support replacement units for its existing customers in the U.S. and Europe through at least the end of calendar year 2011 and will also use the Pro-Dex Product A for all requirements in the South American market through approximately the end of fiscal year 2012.

Regarding Product B, a more complex device, the customer has indicated that the development and testing of that Product has been less successful and that the Company can expect continued orders from the customer for Product B through the end of calendar year 2011.

Lastly, the customer has indicated that it intends to continue to use Pro-Dex’s repair services for all Pro-Dex products for an undetermined period, except in South America, where it will purchase components from Pro-Dex to do its own repairs locally.

As a result of the foregoing, we expect that approximately one-third of the revenue attributable to this customer during calendar year 2011 could move toward them. However, the customer is not obligated to abide by the timetables it has currently expressed to us or to update us as to the status of its product development efforts. Accordingly, we are unable to know or predict the status of the customer’s initiative on an ongoing basis. The customer could accelerate, delay or terminate its transition to its own products at any time and without notice to us, which could have a further material impact on our revenues. The identity of the customer is protected by a confidentiality agreement.

The Company intends to find additional business and reduce its operating costs as necessary to minimize the impact of a potential revenue reduction. In the event that the customer’s future purchases are reduced beyond the additional business won and the cost savings realized, the Company is likely to experience a material and adverse impact on its business.

Issues Related to Credit Facilities

We have a credit facility with Wells Fargo Bank, N.A. (“Wells Fargo”) and a mortgage with Union Bank of California, N.A (“Union Bank”).

 

11


Wells Fargo Credit Facility

As of June 30, 2010, the Wells Fargo credit facility had two components:

 

   

a revolving Credit Line Note (“line of credit”) of up to $1,000,000 in borrowing availability, and

 

   

a Five year Term Note (the “TI Loan”) with an initial balance of $2,000,000, of which $1,366,667 was outstanding as of June 30, 2010.

If borrowings under the line of credit exceed $500,000, the maximum amount of borrowing is limited to the lesser of $1,000,000 or 70% of the eligible accounts receivable plus 40% of the eligible inventory. Its terms require monthly interest payments at either (i) the prime rate of interest (3.25% at June 30, 2010) plus 1.50%, or (ii) three-month LIBOR (0.534% at June 30, 2010) plus 2.50%, at our discretion, based on outstanding borrowings. The line of credit expires on November 1, 2010. We are charged an unused credit line fee of 1.5% per annum payable quarterly on the average balance of the line of credit that is not used. There was no outstanding balance under the credit line as of June 30, 2010. The total eligible additional borrowing capacity under the line of credit as of June 30, 2010 was $1,000,000.

The TI Loan had an initial balance of $2,000,000. The borrowings from this term commitment were used for construction of tenant improvements for our Irvine, California facility. Its terms require monthly principal and interest payments over the 60-month life of the loan, based on outstanding borrowings. The interest rate is fixed at 5.72% over the life of the loan. There was a $1,366,667 outstanding balance under the TI Loan as of June 30, 2010.

All assets of the Company except our Carson City land and building secure the outstanding borrowings under the Wells Fargo credit facility.

Union Bank Mortgage

In March 2006, we entered into a ten-year mortgage with Union Bank for $1,650,000. The principal balance of the mortgage bears interest at a fixed annual rate of 6.73%. Payments on the mortgage are $11,379 per month (based on a 25 year amortization), with the balance of $1,291,666 in principal due on April 1, 2016. The mortgage is secured by our Carson City land and building. There was $1,528,000 in principal outstanding under the mortgage as of June 30, 2010. On September 16, 2010, we paid the remaining $1,519,000 balance due on the mortgage, fully retiring such indebtedness.

There are certain financial and non-financial covenants that the Company must meet to be in compliance with the terms of the Wells Fargo credit facility and mortgage with Union Bank. As of the year ended June 30, 2010, we were in violation of the Wells Fargo annual net income, the quarterly earnings before tax and fixed charge coverage covenants. Wells Fargo waived these violations by a letter agreement on September 17, 2010. We were in compliance with the Union Bank financial covenant, however the Wells violation triggered a cross-default under the Union Bank agreement as of June 30, 2010 that was waived on September 21, 2010.

At June 30, 2010, we had cash and cash equivalents of $3,794,000. We believe that our cash and cash equivalents on hand, together with cash flows from operations, if any, and amounts available under the credit facilities will be sufficient to meet our working capital and capital expenditure requirements for this and the next year.

In September 2002, our Board of Directors authorized the repurchase on the open market of up to 166,667 shares of our outstanding Common Stock at a share price no greater than $3.75, subject to compliance with applicable laws and regulations. There is no requirement that we repurchase all or any portion of such shares. The maximum total value of the repurchase is not to exceed $166,667. From the inception of the repurchase authorization through the fiscal year-end date of June 30, 2003, we repurchased 25,233 shares of Common Stock for $43,741, at an average price of $1.74 per share. No additional shares were repurchased in fiscal years 2004 through 2008. During fiscal year 2009, we repurchased 73,232 shares of common stock for $133,472, at an average price of $1.83 per share. Since the initiation of the buyback program in 2002 through June 30, 2010, we have repurchased 98,465 shares for $177,213 at an average price of $1.80 per share. Our Board suspended the buyback authorization in May 2009 and has not set a reinitiation date for the purchase of our shares pursuant to this program.

Impact of Inflation and Changing Prices

The industries in which we compete are labor intensive, often involving personnel with high-level technical or sales skills. Wages and other expenses increase during periods of inflation and when shortages in the marketplace occur. In addition, suppliers pass along rising costs to us in the form of higher prices. To some extent, we have been able to offset increases in operating costs by increasing charges, expanding services and implementing cost control measures. Nevertheless, our ability to increase prices is limited by market conditions, including international competition in many of our markets.

 

 

12


Recent Accounting Pronouncements

In August 2009, the FASB issued ASU No. 2009-05, “Measuring Liabilities at Fair Value,” (ASU 2009-05) which provides clarification that in circumstances where a quoted market price in an active market for an identical liability is not available, a reporting entity must measure fair value of the liability using one of the following techniques: 1) the quoted prices for similar liabilities or similar liabilities when traded as assets; or 2) another valuation technique, such as a present value technique or the amount that the reporting entity would pay to transfer the identical liability or would receive to enter into the identical liability that is consistent with the provisions of ASC 820, “Fair Value Measurements and Disclosures.” The Company adopted this statement for the quarter ended September 30, 2009. The adoption of ASU 2009-05 did not have a material impact on our financial position or results of operations.

In January 2010, the FASB issued authoritative guidance intended to improve disclosure about fair value measurements. The guidance requires entities to disclose significant transfers in and out of fair value hierarchy levels and the reasons for the transfers and to present information about purchases, sales, issuances, and settlements separately in the reconciliation of fair value measurements using significant unobservable inputs (Level 3). Additionally, the guidance clarifies that a reporting entity should provide fair value measurements for each class of assets and liabilities and disclose the inputs and valuation techniques used for fair value measurements using significant other observable inputs (Level 2) and significant unobservable inputs (Level 3). This guidance is effective for interim and annual periods beginning after December 15, 2009 except for the disclosure about purchases, sales, issuances and settlements in the Level 3 reconciliation, which will be effective for interim and annual periods beginning after December 15, 2010. As this guidance provides only disclosure requirements, the adoption of this standard will not impact the Company’s consolidated financial statements.

The FASB has issued Accounting Standards Codification (ASC) and the Hierarchy of Generally Accepted Accounting Principles (Codification). This authoritative guidance established the Codification, which officially launched on July 1, 2009, to serve as the source of authoritative GAAP recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. The subsequent issuances of new standards will be in the form of Accounting Standards Updates (ASUs) that will be included in the Codification. The Company adopted the Codification for the quarter ended September 30, 2009. The Company’s adoption of the Codification did not have any impact on the Company’s financial position and operations as this change is disclosure-only in nature.

 

13


Item 9A. Controls and Procedures

The Chief Executive Officer and Chief Financial Officer (the principal executive officer and principal financial officer, respectively) conducted an evaluation of the design and operation of our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)). Based on that evaluation as of June 30, 2010, the Chief Executive Officer and the Chief Financial Officer concluded that the disclosure controls and procedures are effective.

Our management is responsible for establishing and maintaining adequate “internal control over financial reporting” (as defined in Rule 13a-15(f) under the Exchange Act). Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework set forth in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of June 30, 2010.

Our internal control over financial reporting is supported by written policies and procedures, that:

(1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of our company are being made only in accordance with authorizations of our management and directors; and

(3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to rules of the SEC that apply to small, non-accelerated filers that permit us to provide only management’s attestation in this annual report.

During the quarter ended June 30, 2010, there were no changes in the Company's internal controls over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, the Company's internal controls over financial reporting.

 

14


Report of Independent Registered Public Accounting Firm

The Stockholders and Board of Directors

Pro-Dex, Inc.:

We have audited the accompanying consolidated balance sheets of Pro-Dex, Inc. and Subsidiaries (the Company) as of June 30, 2010 and 2009 and the related consolidated statements of operations, shareholders’ equity and cash flows for each of the years in the two-year period ended June 30, 2010. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Pro-Dex, Inc. and Subsidiaries as of June 30, 2010 and 2009, and the results of their operations and their cash flows for each of the years in the two-year period ended June 30, 2010 in conformity with accounting principles generally accepted in the United States of America.

 

/s/ Moss Adams LLP

Irvine, California

September 28, 2010

 

15


PRO-DEX, INC. and SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

     30-Jun-10     30-Jun-09  

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 3,794,000      $ 1,124,000   

Accounts receivable, net of allowance for doubtful accounts of $25,000 in 2010 and $52,000 in 2009

     2,682,000        2,515,000   

Other Current Receivables

     22,000        16,000   

Inventories

     3,228,000        3,365,000   

Prepaid expenses

     174,000        117,000   

Prepaid income taxes

     —          118,000   

Deferred income taxes

     209,000        —     
                

Total current assets

     10,109,000        7,255,000   
                

Property, plant, equipment and leasehold improvements, net

     4,092,000        5,981,000   
                

Other assets:

    

Goodwill

     —          2,997,000   

Intangibles—Patents, net

     —          147,000   

Other

     78,000        87,000   
                

Total other assets

     78,000        3,231,000   
                

Total assets

   $ 14,279,000      $ 16,467,000   
                

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

   $ 1,279,000      $ 827,000   

Accrued expenses

     1,947,000        1,394,000   

Income taxes payable

     79,000        53,000   

Current Portion of T.I. Loan

     400,000        400,000   

Current portion of real estate loan

     35,000        33,000   
                

Total current liabilities

     3,740,000        2,707,000   

Long-term liabilities:

    

Notes Payable—T.I. Loan

     967,000        1,367,000   

Real estate loan

     1,493,000        1,528,000   

Deferred income taxes

     209,000        171,000   

Deferred rent

     255,000        212,000   
                

Total long-term liabilities

     2,924,000        3,278,000   
                

Total liabilities

     6,664,000        5,985,000   
                

Commitments and contingencies

    

Shareholders’ equity:

    

Common shares; no par value; 50,000,000 shares authorized; 3,251,850 shares issued and outstanding June 30, 2010 3,222,890 shares issued and outstanding June 30, 2009

     16,675,000        16,574,000   

Accumulated deficit

     (9,060,000     (6,092,000
                

Total shareholders’ equity

     7,615,000        10,482,000   
                

Total liabilities and shareholders’ equity

   $ 14,279,000      $ 16,467,000   
                

See notes to consolidated financial statements.

 

 

16


PRO-DEX, INC. and SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

Years ended June 30

 

     2010     2009  

Net sales

   $ 23,211,000      $ 21,122,000   

Cost of sales

     14,847,000        14,374,000   
                

Gross profit

     8,364,000        6,748,000   

Operating expenses:

    

Selling expense

     1,382,000        1,295,000   

General and administrative expenses

     3,288,000        3,157,000   

Impairment of goodwill

     2,997,000        —     

Impairment of patent

     140,000        997,000   

Impairment of property value

     1,307,000        —     

Research and development costs

     2,480,000        2,791,000   
                

Total operating expenses

     11,594,000        8,240,000   
                

(Loss) from operations

     (3,230,000     (1,492,000

Other:

    

Royalty income

     44,000        14,000   

Interest income

     2,000        2,000   

Interest (expense)

     (204,000     (228,000
                

Total

     (158,000     (212,000
                

(Loss) Income before provision for income taxes

     (3,388,000     (1,704,000

Benefit for Income Taxes

     1,130,000        1,100,000   

Allowance for deferred tax asset

     (710,000     (2,241,000
                

Total Benefit (Provision) for Income taxes

     420,000        (1,141,000
                

Net (Loss)

   $ (2,968,000   $ (2,845,000
                

Net (Loss) per share:

    
                

Basic

   $ (0.92   $ (0.88
                

Diluted

   $ (0.92   $ (0.88
                

Weighted average shares outstanding—basic

     3,232,850        3,236,918   
                

Weighted average shares outstanding—diluted

     3,232,850        3,236,918   
                

See notes to consolidated financial statements.

 

17


PRO-DEX, INC. and SUBSIDIARIES

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

Years ended June 30

 

     Common Shares              
     Number of
Shares
    Amount     Accumulated
Deficit
    Total  

Balance 2007

     3,239,455      $ 16,340,000      $ (3,489,000   $ 12,851,000   
                                

Cumulative retained earnings adjustment for prior years due to accounting standards change (FIN 48)

     —          —          (75,000     (75,000

Issuance of restricted shares and Stock-Based compensation

     28,333        205,000        —          205,000   

Net Income

     —          —          317,000        317,000   
                                

Balance 2008

     3,267,789      $ 16,545,000      $ (3,247,000   $ 13,298,000   
                                

Repurchase of Common Stock

     (73,232     (137,000       (137,000

Issuance of restricted shares and Stock-Based compensation

     28,333        166,000        —          166,000   

Net (Loss)

     —          —          (2,845,000     (2,845,000
                                

Balance 2009

     3,222,890      $ 16,574,000      $ (6,092,000   $ 10,482,000   
                                

Issuance of restricted shares and Stock-Based compensation

     28,334        101,000        —          101,000   

Additional shares due to reverse stock split rounding

     626         

Net (Loss)

     —          —          (2,968,000     (2,968,000
                                

Balance 2010

     3,251,850      $ 16,675,000      $ (9,060,000   $ 7,615,000   
                                

See notes to consolidated financial statements.

 

18


PRO-DEX, INC. and SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

Years ended June 30

 

     2010     2009  

Cash Flows from Operating Activities:

    

Net Income

   $ (2,968,000   $ (2,845,000

Adjustments to reconcile net income to net cash used in operating activities:

    

Depreciation and amortization

     726,000        810,000   

Impairment of intangible asset and property value

     4,444,000        997,000   

Loss on disposal

     —          25,000   

(Recovery of) doubtful accounts

     (27,000     (92,000

Stock based compensation

     101,000        166,000   

Deferred taxes

     (91,000     1,058,000   

Changes in:

    

(Increase) Decrease in accounts receivable

     (146,000     609,000   

Decrease in inventories

     137,000        1,737,000   

(Increase) Decrease in prepaid expenses

     (57,000     97,000   

Decrease (Increase) in other assets

     9,000        (20,000

Increase (Decrease) in accounts payable and accrued expenses

     1,086,000        (1,505,000

Increase in income taxes payable

     26,000        681,000   
                

Net Cash provided by Operating Activities

     3,240,000        1,718,000   
                

Cash Flows From Investing Activities:

    

Purchase of equipment and leasehold improvements

     (137,000     (269,000

Net Cash used in Investing Activities

     (137,000     (269,000
                

Cash Flows from Financing Activities:

    

(Principal) payments of patent deferred payable

     —          (45,000

Net (payments) on Line of Credit

     —          (2,000,000

Principal (payments) on Term Note

     (400,000     (396,000

Net Principal borrowing on TI Loan

     —          1,767,000   

Principal payments on Real Estate Loan

     (33,000     (31,000

Stock Repurchases

     —          (137,000

Net Cash (used in) Financing Activities

     (433,000     (842,000
                

Net increase in Cash and Cash Equivalents

     2,670,000        607,000   

Cash and Cash Equivalents, beginning of year

     1,124,000        517,000   
                

Cash and Cash Equivalents, end of year

   $ 3,794,000      $ 1,124,000   
                

Supplemental Information

    

Cash paid for interest

   $ 204,000      $ 230,000   

Cash paid for income taxes

   $ 154,000      $ —     

See notes to consolidated financial statements.

 

19


PRO-DEX, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2010 and 2009

NOTE 1 – DESCRIPTION OF BUSINESS

Pro-Dex, Inc. specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate miniature rotary drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex’s products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Pro-Dex Astromec, Inc. and Pro-Dex Management, Inc. Pro-Dex Management, Inc. is a non-operating subsidiary. All significant inter-company accounts and transactions have been eliminated.

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with accounting principals generally accepted in the United States of America.

Revenue Recognition

Revenue on virtually all product sales is recognized upon shipment to the customer based on its terms of FOB shipping point, where the risk of loss and title transfer to the customer. We record sales in accordance with ASC 605 (Formerly SEC Staff Accounting Bulletin No. 104, Revenue Recognition.) Under these guidelines, revenue is recognized when all of the following exist: persuasive evidence that a sale arrangement exists, delivery of the product has occurred, the price is fixed or determinable, and payment is reasonably assured. We sell some of our products with a warranty that provides for repairs or replacement of any defective parts for a period after the sale. At the time of the sale, the Company accrues an estimate of the cost of providing the warranty based on prior experience, but does not accrue an allowance for sales returns. The Company recognizes revenue under research and development agreements as certain deliverables are met as specified in each development contract.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of ninety days or less to be cash equivalents.

Accounts Receivable

Trade receivables are carried at original invoice amount less an estimate made for doubtful accounts based on a monthly review of all outstanding amounts. Management determines the allowance for doubtful accounts by identifying troubled accounts and using historical experience applied to an aging of accounts. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are offset against the allowance when received. Changes in reserve for allowance for doubtful accounts are as follows for the years ended June 30, 2010 and 2009:

 

     Fiscal Year Ended June 30,  
     2010     2009  

Balance at the beginning of the year

   $ 52,000      $ 144,000   

Write off of doubtful accounts

     (15,000     (39,000

Collection of doubtful accounts

     (12,000     (53,000

Balance at the end of the year

   $ 25,000      $ 52,000   

 

20


Inventories

Inventories are stated at the lower of cost (the first-in, first-out method) or market and consist of the following at June 30, 2010 and 2009:

 

     Fiscal Year Ended June 30,  
     2010      2009  

Raw Materials

   $ 1,311,000       $ 1,290,000   

Work in process

     607,000         866,000   

Finished goods

     1,310,000         1,209,000   
                 

Total inventories

   $ 3,228,000       $ 3,365,000   
                 

Warranties

The warranty accrual is based on historical costs of warranty repairs and expected future identifiable warranty expenses. Warranty expenses are reflected in the financial statements in Cost of Sales (“COS”). The warranty accrual and expenses for the years ended June 30, 2010 and 2009 are presented below:

 

     Fiscal Year Ended June 30,  
     2010     2009  

Beginning Balance

   $ 518,000      $ 861,000   

Warranties issued during period

   $ 777,000      $ 664,000   

Adjustments to pre-existing warranties due to assumption changes

   $ (58,000   $ (406,000

Settlements (actual expenditures)

   $ (551,000   $ (601,000
                

Ending Balance

   $ 686,000      $ 518,000   

Accrued warranty expense increased during fiscal year ending June 30, 2010 compared to fiscal year ending June 30, 2009 due to more units shipped that were eligible for warranty coverage. The repair costs and expected product return assumptions are reviewed quarterly. The table below reflects the effects on the fiscal year ending June 30, 2010 and 2009 net loss and net loss per share for the assumption changes.

 

     Fiscal Year Ended June 30,  
     2010     2009  

Loss before provision for income taxes—before estimate change

   $ (3,033,000   $ (2,979,000

Add: Impact of change in warranty reserve estimate assumptions

   $ 58,000      $ 406,000   

Less : Tax effect

   $ 7,000      $ (272,000
                

Net Loss after provision of income taxes—after estimate change

   $ (2,968,000   $ (2,845,000
                

EPS—before provision for income taxes—before estimate change

   $ (0.94   $ (0.93

Add: Impact of change in warranty reserve estimate assumptions

   $ 0.02      $ 0.13   

Less : Tax effect

   $ —        $ (0.08
                

EPS—after provision of income taxes—after estimate change

   $ (0.92   $ (0.88

Property, Plant, Equipment & Leasehold Improvements, Net

Property, plant, equipment and leasehold improvements is recorded at historical cost and consists of the following as of June 30, 2010 and 2009:

 

     Fiscal Year Ended June 30,  
     2010     2009  

Land

   $ 278,000     $ 757,000  

Building

   $ 641,000     $ 1,470,000  

Leasehold Improvements

   $ 2,287,000     $ 2,287,000  

Equipment

   $ 6,746,000     $ 6,616,000  
                

Total

   $ 9,952,000     $ 11,130,000  

Accumulated Depreciation

   $ (5,860,000   $ (5,149,000
                

Total property, plant & equipment, net

   $ 4,092,000     $ 5,981,000  
                

 

21


Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Building - 39 years, equipment - 3 to 10 years; and leasehold improvements are depreciated over the shorter of the term of the lease or their estimated useful lives.

We determined a triggering event occurred with the Carson City land and building (“the property”) due to the expected undiscounted cash flows being below the carrying value of the property, indicating impairment. The land was reduced to $370,000 from $757,000 and the building was reduced to $801,000 from $1,470,000. (See Note 10 of the consolidated financial statements.)

Goodwill and Intangible Assets

In accordance with ASC 350 (formerly SFAS No. 142, “Intangible—Goodwill and Other,”) intangible assets with definite lives are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit and adverse legal or regulatory developments. We assess potential impairment of our goodwill and intangible assets when there is evidence that recent events or changes in circumstances have made recovery of an asset’s carrying value unlikely. We also assess potential impairment of our goodwill and intangible assets on an annual basis during our fourth quarter, regardless if there is evidence or suspicion of impairment.

If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flow over the remaining amortization periods, the carrying values are reduced to estimated fair market value. In accordance with ASC 350, a two-step impairment test is required to identify potential goodwill impairment and measure the amount of the goodwill impairment loss to be recognized. In the first step, the fair value of each reporting unit is compared to its carrying amount, including goodwill. If the carrying amount of the reporting unit exceeds its fair value, the second step of the goodwill impairment test is performed to measure the amount of impairment loss, if any. If the fair value of the reporting unit exceeds the carrying amount of the net assets assigned to that unit, then goodwill is not impaired and no further testing is required. (See Note 10 of the consolidated financial statements.)

We base our fair value estimates on assumptions that we believe are reasonable but are uncertain and subject to changes in market conditions. For the purposes of identifying and measuring impairment, goodwill assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flow of other assets and liabilities.

We identify two reporting units for purposes of our annual goodwill impairment testing arising from our acquisitions of Micro Motors and Astromec

 

   

Our Carson City reporting unit corresponds to the operations resulting from the Astromec acquisition,

 

   

Our Irvine reporting unit corresponds to the operations resulting from the Micro Motors acquisition.

During the preparation of the fiscal year 2010 financial statements, we determined a triggering event occurred for Micro Motors as new and replacement revenue sources for a potential loss of our largest customer had not been completed. During the preparation of the fiscal year 2010 financial statements we also determined a triggering event for Astromec as it became apparent that the expected product synergies and resulting financial benefits from the 2006 Astromec acquisition were not being realized. (See Note 10 of the consolidated financial statements).

As the fair value of the reporting units was below the carrying amount at both Astromec and Micro Motors a step 2 analysis was required. In the step two analysis, it was determined that all the remaining goodwill for these two reporting units was impaired. Goodwill impairment associated with Astromec recognized as an operating expense was $1,887,000. Goodwill impairment associated with Micro Motors recognized as an operating expense was $1,110,000.

Long-lived assets

In accordance with ASC 360 (formerly SFAS No. 144, “Accounting for the Impairment or Disposal for Long-Lived Assets”), we review the recoverability of our long-lived assets, such as property and equipment, when events or changes in circumstances occur that indicate the carrying value of the asset group may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of the asset or asset group from the expected future pre-tax cash flows, undiscounted and without interest charges, of the related operations. If these cash flows are less than the carrying value of such assets, an impairment loss is recognized for the difference between estimated fair value and carrying value. The measurement of impairment requires management to estimate future cash flows and the fair value of long-lived assets.

 

 

22


Given the Company’s lack of a direct dental distribution channel, in fiscal year 2009 third quarter, it stopped actively promoting the intraosseous dental anesthesia delivery product (“Intraflow”) that is based on the intangible asset resulting from the purchase of certain assets from IntraVantage, Inc. in October 2005. Any substantial future value therefore is derived from the possibility that a company with a direct dental distribution channel (a “Market Participant”) might be interested in access to the technology through product purchases, licenses, acquisition, joint venture, or other means. Given the current economic environment, the general lack of investment in new products, the limited number of Market Participants to whom this technology relates, the time and expense necessary to consummate a transaction, and other factors considered by management, there is also a significant possibility that no distribution partner will be found, resulting in effectively no value of the asset. Given this change in circumstance, in accordance with ASC 360 (formerly SFAS No. 144 “Accounting for the Impairment or Disposal of Long-Lived Assets.”) management tested the carrying amount of the intangible asset for recoverability as of March 31, 2009. The result of management’s analysis (based on several scenarios with varying probabilities of occurring) was that the asset’s value was impaired and, accordingly, a charge of $997,000 was taken in the fiscal 2009 third quarter. As market conditions have not improved and no distribution partner has been found as of December 31, 2009, management concluded that the asset’s value was further impaired and, accordingly, a charge for the remaining value of $140,000 was taken in the fiscal 2010 second quarter.

 

     Carrying Value  
     6/30/2009      Amortization     Impairment     6/30/2010  

Intangibles – Patents

   $ 147,000       $ (7,000   $ (140,000   $   

We determined a triggering event occurred with the Carson City land and building (“the property”) due to the expected undiscounted cash flows being below the carrying value of the property, indicating impairment. The fair value is defined pursuant to ASC 820 – Fair Value Measurements as the price that would be received in an orderly transaction between market participants at the measurement date. The fair value was estimated based on market conditions and comparable transactions.

 

     Carrying Value  
     6/30/2009     Depreciation     Impairment     6/30/2010  

Land

   $ 757,000        $ (478,000   $ 279,000   

Building

   $ 1,470,000        $ (829,000   $ 641,000   
                                

Accumulated Depreciation

   $ (122,000   $ (38,000   $ —        $ (160,000
                                

Total Land & Building, net

   $ 2,105,000      $ (38,000   $ (1,307,000   $ 760,000   
                                

Stock Repurchase Plan

In September 2002, our Board of Directors authorized the repurchase on the open market of up to 166,667 shares of our outstanding Common Stock at a share price no greater than $3.75, subject to compliance with applicable laws and regulations. There is no requirement that we repurchase all or any portion of such shares. The maximum total value of the repurchase is not to exceed $166,667. From the inception of the repurchase authorization through the fiscal year-end date of June 30, 2003, we repurchased 25,233 shares of Common Stock for $43,741, at an average price of $1.74 per share. No additional shares were repurchased in fiscal years 2004 through 2008. During fiscal year 2009, we repurchased 73,232 shares of common stock for $133,472, at an average price of $1.83 per share. Since the initiation of the buyback program in 2002 through June 30, 2010, we have repurchased 98,465 shares for $177,213 at an average price of $1.80 per share. Our Board suspended the buyback authorization in May 2009 and has not set a reinitiation date for the purchase of our shares pursuant to this program.

 

     (a)      (b)      (c)      (d)  

Period

   Total Number
of Shares
Purchased
     Average Price
Paid Per Share
     Total Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs
     Maximum Number
(Approximate Dollar Value)
of Shares that May Yet be
Purchased Under the Plans
or Programs
 

July 1-31, 2008

     5,233       $ 2.97         30,467         136,200 ($440,719)   

August 1-31, 2008

     2,333       $ 2.82         32,800         133,867 ($434,109)   

September 1-30, 2008

     14,076       $ 2.61         46,876         119,790 ($397,335)   

October 1-31, 2008

     12,050       $ 2.07         58,926         107,740 ($372,311)   

November 1-30, 2008

     2,850       $ 1.68         61,776         104,891 ($367564)   

December 1-31, 2008

     8,154       $ 1.26         69,930         96,737 ($357,235)   

January 1-31, 2009

     2,784       $ 1.32         72,714         93,953 ($352,324)   

February 1-28, 2009

     4,417       $ 1.23         77,131         89,535 ($349,190)   

March 1-31, 2009

     7,299       $ 1.11         84,430         82,236 ($343,994)   

April 1-30, 2009

     14,035       $ 1.21         98,465         68,201 ($322,787)   

FY 2009 Total

     73,232       $ 1.83         98,465         68,201 ($322,787)   

 

23


Income Taxes

Deferred income taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences, operating losses, and tax credit carry forwards. Deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Shipping and Handling

The Company includes payments from its customers for shipping and handling in its net revenues line item in accordance with ASC 605 (formerly Emerging Issues Task Force (“EITF”) 00-10, Accounting for Shipping and Handling Fees and Costs. Shipping expenses, which consist primarily of payments made to freight companies, are reported in cost of goods sold.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to credit risk consist principally of cash and trade receivables. The Company places its cash with major financial institutions. At June 30, 2010 and 2009 and at various times throughout 2010 and 2009 the Company had deposits in excess of federally insured limits. Credit sales are made to resellers located throughout the world, and account for a substantial portion of trade receivables. Such receivables are not collateralized, but we do monitor our customer’s payment history.

Stock Options and Warrants

We are subject to ASC 718 (formerly SFAS No. 123 (R) Accounting for Stock-Based Compensation as revised December 2004.) This standard establishes the accounting standards for equity compensation, and applies to us in the recognition of the cost of stock options awarded based on the grant-date fair value of those awards.

Under ASC 718, the fair value of stock-based awards to employees can be calculated through the use of option pricing models, even though such models were developed to estimate the fair value of freely tradable, fully transferable options with vesting restrictions which significantly differ from the Company’s stock option awards. These models require subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated value. The volatility assumption is based on historical actual activity, with the future volatility expected to equal the past volatility. The expected time to exercise is based on the simplified model of the vesting time plus  1/2 the option life. The Company’s calculations for the options granted were made using the Black-Scholes option-pricing model. The calculations are based on a single-option valuation approach and forfeitures are recognized.

The fair value and associated compensation cost of each grant is estimated at the grant date using the Black-Scholes option-pricing model with the following weighted-average assumptions: no dividend rate for all years; price volatility of 49% to 57% in 2009, of 41% to 52% in 2010; risk-free interest rates of approximately 2.4% to 3.0% in 2009 and 3.3% to 4.9% in 2010; and expected lives of five to eight years.

Use of Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

The Company’s operations are affected by numerous factors including market acceptance, changes in technologies and new laws and government regulations and policies. The Company cannot predict what impact, if any, the occurrence of these or other events might have on the Company’s operations. Significant estimates and assumptions made by management include, but are not limited to: revenue recognition, the allowance for doubtful accounts, warranty reserve, inventory valuation for slow moving items, the carrying value of long-lived and intangible assets impairment of goodwill, and the recovery of deferred income tax assets.

Significant management judgment is required to determine our provision for income taxes and the recoverability of the deferred tax asset. It is based on estimates of future taxable income by jurisdiction in which the Company operates and the period over which the deferred tax assets will be recoverable. In the event that actual results differ from these estimates or we adjust these estimates in future periods, a valuation allowance may need to be established which could result in a tax provision equal to the carrying value of the deferred tax assets.

 

24


Earnings per Share

Basic earnings per common share data has been computed on the basis of the weighted-average number of common shares outstanding during each period presented. Diluted per share amounts assume the conversion, exercise or issuance of all potential common stock instruments unless the effect is to increase the income or decrease the loss per common share from continuing operations.

Fair Value of Financial Instruments

Fair Value Measurements — Effective July 1, 2008, the Company adopted ASC 820 (formerly Statement of Financial Accounting Standards No. 157, “Fair Value Measurements”) for financial assets and liabilities measured at fair value on a recurring basis. (See note 9) ASC 820 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements.

Research and Development

Research and development costs, which are charged to expense as incurred, support the development of generic rotary drive, motion control and electric motor technology platforms.

Advertising

Advertising costs are not capitalized, as all advertising expenditures are recognized in the period incurred as a selling expense. In the year ended June 30, 2010, we recognized $127,000 for advertising, compared to $102,000 in the year ended June 30, 2009.

NOTE 3 – BANK DEBT

We have a credit facility with Wells Fargo Bank, N.A. (“Wells Fargo”) and a mortgage with Union Bank of California, N.A (“Union Bank”).

Wells Fargo Credit Facility

As of June 30, 2010, the Wells Fargo credit facility had two components:

 

   

a revolving Credit Line Note (“line of credit”) of up to $1,000,000 in borrowing availability, and

   

a Five year Term Note (the “TI Loan”) with an initial balance of $2,000,000, of which $1,366,667 was outstanding as of June 30, 2010.

If borrowings under the line of credit exceed $500,000, the maximum amount of borrowing is limited to the lesser of $1,000,000 or 70% of the eligible accounts receivable plus 40% of the eligible inventory. Its terms require monthly interest payments at either (i) the prime rate of interest (3.25% at June 30, 2010) plus 1.50%, or (ii) three-month LIBOR (0.534% at June 30, 2010) plus 2.50%, at our discretion, based on outstanding borrowings. The line of credit expires on November 1, 2010. We are charged an unused credit line fee of 1.5% per annum payable quarterly on the average balance of the line of credit that is not used. There was no outstanding balance under the credit line as of June 30, 2010. The total eligible additional borrowing capacity under the line of credit as of June 30, 2010 was $1,000,000.

The TI Loan had an initial balance of $2,000,000. The borrowings from this term commitment were used for construction of tenant improvements for our Irvine, California facility. Its terms require monthly principal and interest payments over the 60-month life of the loan, based on outstanding borrowings. The interest rate is fixed at 5.72% over the life of the loan. There was a $1,366,667 outstanding balance under the TI Loan as of June 30, 2010.

All assets of the Company except our Carson City land and building secure the outstanding borrowings under the Wells Fargo credit facility.

Union Bank Mortgage

In March 2006, we entered into a ten-year mortgage with Union Bank for $1,650,000. The principal balance of the mortgage bears interest at a fixed annual rate of 6.73%. Payments on the mortgage are $11,379 per month (based on a 25 year amortization), with the balance of $1,291,666 in principal due on April 1, 2016. The mortgage is secured by our Carson City land and building. There was $1,528,000 in principal outstanding under the mortgage as of June 30, 2010. On September 16, 2010, we paid the remaining $1,519,000 balance due on the mortgage, fully retiring such indebtedness.

 

 

25


There are certain financial and non-financial covenants that the Company must meet to be in compliance with the terms of the Wells Fargo credit facility and mortgage with Union Bank. As of the year ended June 30, 2010, we were in violation of the Wells Fargo annual net income, the quarterly earnings before tax and fixed charge coverage covenants. Wells Fargo waived these violations by a letter agreement on September 17, 2010. We were in compliance with the Union Bank financial covenant, however the Wells violation triggered a cross-default under the Union Bank agreement as of June 30, 2010 that was waived on September 21, 2010.

NOTE 4 – COMMITMENTS AND CONTINGENCIES

The Company leases its existing office and warehouse facilities in Irvine, California and Beaverton, Oregon. The Irvine lease expires in March 2018 and the Beaverton lease expires in April 2014. These leases require the Company to pay insurance, taxes, and other expenses related to the leased space. Total rent expense in 2010 and 2009 was $568,000 and $572,000, respectively. Future minimum lease payments for the fiscal year ending June 30 are:

 

2011

   $ 488,000   

2012

   $ 508,000   

2013

   $ 527,000   

2014

   $ 532,000   

2015

   $ 478,000   

2016-2018

   $ 1,399,000   
        

Total

   $ 3,932,000   
        

Our manufacture and distribution of certain products involves a risk of legal action, and, from time to time, we are named as defendants in lawsuits. It is not reasonably possible to estimate the awards or damages, or the range of awards or damages, if any, we might incur in connection with such litigation. Other than the case pending with the Orange County Water District discussed below, management is not aware of any material actual, pending or threatened litigation at this time.

On June 23, 2008, the Orange County Water District (“OCWD”) filed a complaint in the Superior Court of the State of California in the County of Orange concerning remediation of alleged ground water contamination in the Orange County Groundwater South Basin; Orange County Water District v. Sabic Innovative Plastics U.S. LLC, et al., Case No. 00078246. The South Basin underlies parts of Santa Ana, California and adjacent cities. The complaint identifies 17 named defendants, including Pro-Dex, and also designates 400 unnamed Doe defendants. We moved out of this Santa Ana site in April, 2008 and have no remaining operations there. Since January 1, 2009, OCWD has named 11 additional defendants by multiple amendments to its complaint.

The complaint alleges that the defendants contaminated the South Basin with volatile organic chemicals (“VOCs”) and perchlorate through various activities at properties each defendant now controls or has controlled in the past. Through its lawsuit, the OCWD seeks compensatory relief for all its own remedial activities, and injunctive relief to compel the defendants to undertake remedial activities in general. The complaint does not, however, specify any remedial activities that the OCWD has undertaken to date or any remedial activities that it seeks any particular defendants to undertake. Moreover, from our investigation of OCWD’s remedial activities to date, we have determined that the OCWD is in the early stages of its remedial investigation for the South Basin groundwater contamination. In two recent Case Management Conferences before the court, OCWD has refused defendants’ request to designate a date by which it will disclose its proposed soil and groundwater cleanup remedies.

As noted above, 27 other entities are named defendants in this case along with Pro-Dex. While some are small businesses, others are larger corporations or their subsidiaries. Further, as this case progresses, the OCWD is likely to add at least a few more named defendants to the case from the 400 Doe defendants it has designated in the current complaint. In the indeterminable event that we would be held liable in the case, OCWD’s total recovery probably would be allocated among several defendants, each of which would pay only a proportionate share of that total recovery.

One of our past insurers has committed to pay most of our defense costs for the lawsuit, and has done so to date, while reserving its rights as to whether it will cover any damages awarded against us, or any settlement payment to which Pro-Dex agrees to resolve the lawsuit, under past policies issued to us for a three-year period, March 31, 1983 to March 31, 1986. The policies of these years have occurrence payment limits of $500,000.

Overall, the OCWD complaint remains vague, the OCWD is in an early stage of its remedial activities in the South Basin, the lawsuit is in the early stages of discovery, one of our insurers has committed to pay most defense costs and has reserved rights under one three-year set of policies and is continuing to consider extending coverage to us under other past policies, and any recovery the OCWD may gain through the lawsuit is likely to be allocated among several defendants. Therefore, our liabilities, as well as our costs of defending, monitoring and concluding our involvement in this case are uncertain, and those costs cannot now be estimated.

 

26


NOTE 5 – INCOME TAXES

The provisions for income taxes for the years ended June 30, 2010 and 2009 are as follows:

 

     Fiscal Year ended June 30,  
     2010     2009  

Current:

    

Federal

   $ (227,000   $ 97,000   

State

     (22,000     (14,000

Deferred:

    

Federal

     (141,000     587,000   

State

     (30,000     471,000   
                

Provision for Income taxes

   $ (420,000   $ 1,141,000   
                

A reconciliation of the expected tax to the amount computed by applying the federal statutory income tax rates to income before income taxes is as follows:

 

     Fiscal Year ended June 30,  
     2010     2009  

Federal income tax provision at the statutory rate

   $ (1,152,000   $ (579,000

Change in valuation allowance for deferred tax assets

   $ 710,000      $ 2,241,000   

State income taxes, net of federal tax benefit

     (122,000     (275,000

Tax incentives

     (467,000     (255,000

Goodwill impairment

     322,000     

Non-deductible items

     88,000        28,000   

Unrecognized tax benefits

     176,000        (19,000

Other

     25,000        —     
                

(Benefit from)/Provision for income taxes

   $ (420,000   $ 1,141,000   
                

Deferred income tax assets and liabilities in the accompanying consolidated balance sheet at June 30, 2010 and 2009 are as follows:

 

     Fiscal Year ended June 30,  
Deferred tax assets/(liabilities) current:    2010     2009  

Deferred tax assets

    

Accrued expenses

   $ 609,000      $ 316,000   

Inventories

     581,000        830,000   

Net operating losses

     112,000        680,000   

State taxes

     (13,000     87,000   

Income tax credit carry forwards

     —          —     
                

Total deferred tax assets (current)

     1,289,000        1,913,000   

Valuation Allowance

     (1,080,000     (1,297,000
                

Current Deferred tax assets, net

   $ 209,000      $ 616,000   
                

 

     Fiscal Year ended June 30,  
Deferred tax assets/(liabilities) non-current:    2010     2009  

Deferred rent

   $ 105,000      $ 87,000   

Intangible assets

     1,178,000        493,000   

Non-cash stock based comp

     —          16,000   

Income tax credit carry forwards

     748,000        569,000   

State taxes

     24,000        (76,000

Depreciation

     (393,000     (932,000
                

Total deferred tax assets (non-current)

     1,662,000        157,000   

Valuation allowance

     (1,871,000     (944,000
                

Non-Current Deferred tax assets/(liabilities) , net

   $ (209,000   $ (787,000
                

 

27


We have state net operating loss carry forwards for June 30, 2010 and 2009 of $1,541,000 and $2,305,000, respectively. The Company has federal tax credits of $337,000 and $276,000 for June 30, 2010 and 2009, respectively, and state tax credits of $411,000 and $285,000 for June 30, 2010 and 2009, respectively.

Significant management judgment is required in determining our provision for income taxes and the recoverability of our deferred tax asset. Such determination is based primarily on our historical taxable income, with some consideration given to our estimates of future taxable income by jurisdictions in which we operate and the period over which our deferred tax assets will be recoverable. Due to cumulative taxable losses during the past three years, we recorded $2,241,000 valuation allowance against our deferred tax assets in the year ended June 30, 2009 and an additional $710,000 in 2010.

A reconciliation of the beginning and ending amount of valuation allowance is as follows:

 

Balance at July 1, 2009

     (2,241,000

Increase in tax asset valuation allowance

     (710,000
        

Balance at June 30, 2010

   $ (2,951,000
        

The change in valuation allowance is due primarily to the change in the Company’s deferred tax assets and liabilities resulting from the revaluation of land and buildings and from the impairment of goodwill.

As of June 30, 2010, pursuant to ASC 740 (formerly FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes), we have accrued $230,000 of unrecognized tax benefits related to state income tax matters that would reduce the Company’s income tax expense if recognized and would result in a corresponding decrease in the Company’s effective tax rate.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

Balance at July 1, 2009

   $ 54,000   

Additions based on tax positions related to the current year

     31,000   

Additions for tax positions of prior years

     145,000   

Reductions for tax positions of prior years

     0   

Settlements

     0   
        

Balance at June 30, 2010

   $ 230,000   
        

We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. As of June 30, 2010, there was no interest or penalties applicable to our unrecognized tax benefits since the company has sufficient tax attributes available to fully offset any potential assessment of additional tax.

Pro-Dex and its subsidiaries are subject to U.S. federal income tax, as well as income tax of multiple state tax jurisdictions. We are currently open to audit under the statute of limitations by the Internal Revenue Service for the years ended June 30, 2007 and later. Our state income tax returns are open to audit under the statute of limitations for the years ended June 30, 2006 and later. We do not anticipate a significant change to the total amount of unrecognized tax benefits within the next 12 months.

 

28


NOTE 6 – SHARE-BASED COMPENSATION

Stock Options

The Board of Directors and the shareholders of the Company have approved and adopted two equity compensation plans, pursuant to which (i) options to purchase common stock or ii) restricted shares, may be granted up to an aggregate amount of 833,333 shares of common stock to officers, directors, and employees of the Company. Upon its adoption, the employee stock option plan had 666,667 shares of common stock available for issuance and the directors’ plan had 166,667 shares of common stock available for issuance. The option plans are substantially similar, call for vesting as approved by the Board of Directors of six months for directors and up to five years for employees, and allow for the options to be outstanding for a period of up to ten years but are forfeited 30 days after the holder ceases to be an employee and are forfeited 90 days after the holder ceases to be director. There are options to purchase 113,349 shares remaining under the employee option plan and options to purchase 23,334 shares remaining under the directors option plan for a total of 156,682 shares remaining under both option plans at June 30, 2010, that are available to grant in future years. New shares are issued as such options are exercised or restricted shares are granted. Share-based compensation expense reduced the Company’s results of operations as shown:

 

     Fiscal Year ended
June 30,
 
     2010      2009  

Share-based compensation expense recognized:

     

General and administrative, options

     23,000         49,000   

General and administrative, restricted stock

     78,000         117,000   
                 

Subtotal expense

     101,000         166,000   

Related deferred tax benefit

     —           —     
                 

Decrease in net income

     101,000         166,000   
                 

Decrease in basic earnings per share

   $ 0.03       $ 0.05   

Decrease in diluted earnings per share

   $ 0.03       $ 0.05   
                 

As of June 30, 2010, there was $24,000 of total unrecognized compensation cost related to 34,167 non vested outstanding stock options with a per share weighted average value of $2.88. The unrecognized expense is anticipated to be recognized on a straight-line basis over a weighted average period of 0.7 years.

The following is a summary of stock option activity:

 

     2010      2009  

Fixed Options

   Shares     Weighted-Average
Exercise Price
     Shares     Weighted-Average
Exercise Price
 

Outstanding at beginning of year

     311,000      $ 4.26         369,833      $ 4.74   

Granted

     22,000        1.57         35,333        1.86   

Exercised

     —          —           —          —     

Forfeited

     (139,167     4.29         (94,167     5.25   
                                 

Outstanding at end of year

     193,833      $ 3.94         311,000      $ 4.26   

Exercisable at end of year

     173,000      $ 4.08         276,917      $ 4.38   

Weighted-average fair value per Option granted during the year

     $ 0.66         $ 0.84   

The following table summarizes information regarding options outstanding and options exercisable at June 30, 2010:

 

     Options Outstanding      Options Exercisable  

Range of Exercise Price

   Number
Outstanding
     Weighted-Average
Remaining
Contractual Life
     Weighted-Average
Exercise Price
     Aggregate
Intrinsic
Value
     Number
Outstanding
     Weighted-Average
Exercise Price
     Aggregate
Intrinsic
Value
 

$1.26 to $2.43

     83,000         5.5 years       $ 1.68       $ 29,050         71,000       $ 1.45       $ 24,790   

$3.00 to $4.68

     61,000         6.1 years         4.18       $ —           52,000         3.55       $ —     

$5.22 to $5.76

     20,000         4.5 years         5.51       $ —           20,000         5.51       $ —     

$7.65 to $9.90

     30,000         5.0 years         8.66       $ —           30,000         8.66       $ —     
                                                              

Total

     194,000         4.2 years       $ 3.94       $ 29,050         173,000       $ 4.08       $ 24,790   
                                                              

 

29


Restricted Stock

In connection with the employment agreement with our Chief Executive Officer, a restricted stock grant of 113,334 shares of common stock was made in February 2007. These shares vest in four equal installments of 25% or 28,333 shares per year over 4 years. The common stock price at the date of the grant was $4.14. New shares are issued with the vesting of each installment of restricted stock. The fair value of the grant is calculated as the number of shares multiplied by the grant price. The compensation expense is recognized over the vesting period of the grant. Approximately $78,000 in compensation expense for the restricted stock was recognized in fiscal year 2010.

The following is a summary of restricted share activity:

 

     2010      2009  

Restricted shares

   Shares     Weighted-Average
Exercise Price
     Shares     Weighted-Average
Exercise Price
 

Outstanding at beginning of year

     28,333      $ 4.14         56,667        4.14   

Granted

     —          —           —          —     

Vested

     (28,333     4.14         (28,333     4.14   

Forfeited

     —          —           —          —     
                                 

Outstanding at end of year

     —             28,333      $ 4.14   

Exercisable at end of year

     —        $ —           —        $ —     

As of June 30, 2010, there was no unrecognized compensation cost related to non vested outstanding restricted shares as all restricted shares have vested and were exercised.

NOTE 7 – NET INCOME PER SHARE

Potentially dilutive securities are not included in the diluted loss per share calculation due to net losses from continuing operations in the last two years so there is no difference to reconcile for the weighted average shares outstanding for basic and diluted net income per share for the years ended June 30.

Potentially dilutive securities not included in the diluted loss per share calculation due to net losses from continuing operations and for options that have a strike price higher than the market price for our common stock (no intrinsic value) are as follows:

 

     2010      2009  

Options to purchase common shares

     601,956         278,598   

Restricted Shares

     —           16,998   
                 

Total potentially dilutive securities not included

     601,956         292,595   

NOTE 8 – MAJOR CUSTOMERS

 

We had two major customers (defined as a customer that represented greater than 10% of the Company’s total revenues) in the year ended June 30, 2010 and 2009.

 

     Year ended June 30,  
     2010      2009  
     Revenues      Accts. Rec.      Revenues      Accts. Rec.  

Customer 1

   $ 4,770,000       $ 365,000       $ 4,232,000       $ 513,000   

Customer 2

   $ 9,268,000       $ 1,097,000       $ 6,530,000       $ 730,000   

In December, 2009 our largest customer informed us that is was in the process of developing, and planned to eventually manufacture, its own surgical hand pieces which are functionally comparable to the two products currently provided to the customer by the Company. Pro-Dex has been the exclusive manufacturer of these products since they were developed.

 

30


We currently provide the Customer with two products (“Product A” and “Product B”) and repair services for such products. Total revenue shipped in the last two fiscal years by each of these categories is as follows:

 

     Revenues during the 12
months ended
        
     6/30/2010      6/30/2009      Average % of Total  

Product A

   $ 4,398,000       $ 2,851,000         46

Product B

   $ 3,965,000       $ 2,717,000         42

Repairs

   $ 905,000       $ 962,000         12
                          
   $ 9,268,000       $ 6,530,000         100

The customer has indicated that it has successfully developed, tested, and released its version of Product A and is currently shipping such product to new accounts. The customer has also indicated that it intends to continue to purchase from Pro-Dex sufficient levels of Product A to support replacement units for its existing customers in the U.S. and Europe through at least the end of calendar year 2011 and will also use the Pro-Dex Product A for all requirements in the South American market through approximately the end of fiscal year 2012.

Regarding Product B, a more complex device, the customer has indicated that the development and testing of that Product has been less successful and that the Company can expect continued orders from the customer for Product B through the end of calendar year 2011.

Lastly, the customer has indicated that it intends to continue to use Pro-Dex’s repair services for all Pro-Dex products for an undetermined period, except in South America, where it will purchase components from Pro-Dex to do its own repairs locally.

As a result of the foregoing, we expect that approximately one-third of the revenue attributable to this customer during calendar year 2011 could move toward them. However, the customer is not obligated to abide by the timetables it has currently expressed to us or to update us as to the status of its product development efforts. Accordingly, we are unable to know or predict the status of the customer’s initiative on an ongoing basis. The customer could accelerate, delay or terminate its transition to its own products at any time and without notice to us, which could have a further material impact on our revenues. The identity of the customer is protected by a confidentiality agreement.

The Company intends to find additional business and reduce its operating costs as necessary to minimize the impact of a potential revenue reduction. In the event that the Customer’s future purchases are reduced beyond the additional business won and the cost savings realized, the Company is likely to experience a material and adverse impact on its business.

NOTE 9 – FAIR VALUE MEASUREMENTS

Fair Value Measurements — Effective July 1, 2008, the Company adopted ASC 820 (formerly Statement of Financial Accounting Standards No. 157, “Fair Value Measurements”) for financial assets and liabilities measured at fair value on a recurring basis. ASC 820 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements. In addition to expanding the disclosures surrounding fair value measurements, ASC 820 indicates that fair value represents the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is determined based upon assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

 

   

Level 1—Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

   

Level 2—Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

 

   

Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of the fair value hierarchy described above. The lowest level of significant input determines the placement of the entire fair value measurement in the hierarchy.

 

31


The following valuation methodology was used for the company’s assets to measure fair value at June 30, 2010:

Cash and cash equivalents: The carrying value of cash and cash equivalents is considered to be representative of their fair values based on the short term nature of these instruments. As such these investments are classified within level 1 of the valuation hierarchy.

Although the methods above may produce a fair value calculation that may not be indicative of the net realizable value or reflective of future fair values, the Company believes its valuation methods are appropriate.

The use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

The following fair value hierarchy table presents information about the Company’s assets measured at fair value on a recurring basis as of June 30, 2010:

 

Description

   Level 1      Level 2      Level 3      Total  

Cash and cash equivalents

   $ 3,794,000             $ 3,794,000   
                                   

Total

   $ 3,794,000       $ —         $ —         $ 3,794,000   
                                   

We determined a triggering event occurred with the Carson City land and building (“the property”) due to the expected undiscounted cash flows being below the carrying value of the property, indicating impairment.

We based the fair value of our Carson City land and building on estimated prices in an inactive market, where indications of prices can be observed indirectly from other transactions. The fair value was estimated based on current market conditions as the price that would be received in an orderly transaction between market participants at the measurement date.

The following fair value hierarchy table presents information about the Company’s assets measured at fair value on a nonrecurring basis as of June 30, 2010:

 

June 30, 2010

   Fair Value      Level 1      Level 2      Level 3  

Land

     279,000            279,000      

Building

     481,000            481,000      
                                   

Total fixed assets

     760,000            760,00      
                                   

NOTE 10 – INTANGIBLE ASSET IMPAIRMENT

In estimating the fair value of the reporting units, we considered the three traditional approaches to valuation, the market approach and the income (discounted cash flow “DCF”) approach. The market approach compares the subject company with guideline publicly-traded companies. Valuation multiples are calculated from the selected companies to provide an indication of how much a current investor in the marketplace would be willing to pay for a company with similar characteristics. The income approach measures the projected cash flows expected to be realized from the asset. The value of a business is the expected cash flows discounted to a present value at a discount rate that considers the degree of risk associated with the realization of the projected monetary benefits. The cash flow analysis relies upon estimates of the entity’s future revenue and expenses to ultimately project the future cash flows resulting from the business activity of each entity. An appropriate discount rate is reached by calculating the weighted average cost of capital “WACC,” which is determined by the assumptions underlying the Capital Asset Pricing Model “CAPM” and is considered to reflect the view of “Market Participants,” as required under ASC 825 (formerly SFAS 157).

 

32


The material assumptions relied upon in the analyses used to value the Micro Motors and Astromec reporting units and goodwill are shown below.

Astromec

 

  3) Market Approach

 

  (a) Nine public companies were identified that had a range of revenue to value multiples of between 0.19 times to a high of 1.02 times with a median revenue multiple of 0.43.

 

  (b) Eleven similar open market transactions were identified that had revenue to value multiples that ranged from a low of 0.25 to a high of 0.77 with a median revenue multiple of 0.56

 

  (c) The low multiples were used to determine the fair value due to Astromec’s small size and profitability.

 

  4) Income Approach

 

  (a) A discounted cash flow model was constructed using a ten –year forecast for the reporting unit to determine a debt-free cash flow forecast. The present value of the cash flows and residual value were discounted to a present value using the WACC.

 

  1. The inputs to the CAPM to determine the cost of equity used in the WACC were:

 

  i. Risk free rate of 3.74%

 

  ii. Relevered Beta of 1.24

 

  iii. Equity risk premium of 5.18%

 

  iv. Small cap stock premium of 6.28%

 

  v. Reporting unit risk premium of 2.0%

 

  2. The reporting unit’s cost of equity was estimated to be 16.4%

 

  (b) The cost of debt was 6.05% based on Moody’s Baa seasoned bond rate.

 

  (c) Based on the debt/equity capital structure of the peer group of 83% equity and 17% debt, the WACC was estimated at 15.8%.

Micro Motors

 

  3) Market Approach

 

  (a) Ten public companies were identified that had a range of revenue to value multiples of between 0.20 times to a high of 1.00 times with a median revenue multiple of 0.47.

 

  (b) Eleven similar open market transactions were identified that had revenue to value multiples that ranged from a low of 0.25 to a high of 0.77 with a median revenue multiple of 0.56

 

  (c) The mean multiples were used to determine the fair value due to Micro Motor’s size.

 

  4) Income Approach

 

  (a) A discounted cash flow model was constructed using a ten–year forecast for the reporting unit to determine a debt-free cash flow forecast. The present value of the cash flows and residual value were discounted to a present value using the WACC.

 

  1. The inputs to the CAPM to determine the cost of equity used in the WACC were:

 

  i. Risk free rate of 3.74%

 

  ii. Relevered Beta of 0.85

 

  iii. Equity risk premium of 5.18%

 

  iv. Small cap stock premium of 6.28%

 

33


  2. The reporting unit’s cost of equity was estimated to be 14.4%

 

  (b) The cost of debt was 6.05% based on Moody’s Baa seasoned bond rate.

 

  (c) Based on the debt/equity capital structure of the peer group of 83% equity and 17% debt, the WACC was estimated at 12.5%.

As the fair value of the equity was below the carrying value of the equity at both Astromec and Micro Motors, the goodwill was considered impaired and a step 2 analysis was required. In the step two analysis, it was determined that all the remaining goodwill for these two reporting units was impaired. Goodwill impairment associated with Astromec recognized as an operating expense was $1,887,000. Goodwill impairment associated with Micro Motors recognized as an operating expense was $1,110,000.

NOTE 11 – SUBSEQUENT EVENTS

We have evaluated events or transactions that occurred after the balance sheet date of June 30, 2010 through September 24, 2010.

1) On July 7, 2010 The Nasdaq Stock Market notified the Company that it had regained compliance with the minimum $1.00 per share bid price requirement for continued listing, and further, that it complies with all other applicable standards for continued listing on The Nasdaq Stock Market. Accordingly, the Company continues to be listed on The NASDAQ Stock Market.

2) On July 14, 2010, the Board of Directors (the “Board”) of Pro-Dex, Inc. (the “Company”) acting in executive session and upon recommendation of the Company’s Compensation Committee, approved:

A Long-Term Incentive Plan (the “LTIP”) to provide equity-based incentive opportunities for the Company’s executives and other key personnel.

An Annual Incentive Plan (the “AIP”) to provide annual cash-based incentive opportunities for the Company’s key employees.

A new compensation plan for non-employee directors of the Board, effective as of July 1, 2010

3) On July 14, 2010, the Company and Mark P. Murphy, the Chief Executive Officer of the Company, entered into an at-will employment arrangement (“Employment Arrangement”). Under the terms of the Employment Arrangement, Mr. Murphy will report to the Board and a summary of his compensation will consist of the following components:

 

   

A base salary at an annualized rate of $300,000.

 

   

An initial grant of 50,000 stock options.

 

   

Participation in all Company incentive compensation plans open to senior executives of the Company.

 

   

If Mr. Murphy’s employment with the Company terminates for any reason, the Company shall pay one year of severance compensation equal to one (1.0) times his then-current annual base salary, plus (ii) any AIP or LTIP awards earned but not yet paid as of the termination date.

4) The contingent liability for the value of expired options awarded to the Company’s former Executive Vice President and Chief Business Development Officer, Patrick Johnson, expired on August 7, 2010.

 

  5) On September 16, 2010, we paid the remaining $1,519,000 balance due on the Union Bank mortgage, fully retiring such indebtedness.

 

34


Index to Exhibits

 

Exhibit
No.
   Document
23.1 xx    Consent Letter of Moss Adams LLP.
31.1 xx    Certification of the Chief Executive Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 xx    Certification of the Chief Financial Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32 xx    Certifications of the Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

xx 

Filed Herewith

 

35


SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

PRO-DEX INC.

/s/ Mark P. Murphy

Mark P. Murphy
President, Chief Executive Officer and Director
(Principal Executive Officer)

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

/s/ Mark P. Murphy

   

May 16, 2011

 
Mark P. Murphy     Date  
President, Chief Executive Officer and Director      
(Principal Executive Officer)      

/s/ Harold A. Hurwitz

   

May 16, 2011

 
Harold A. Hurwitz     Date  
Treasurer, Chief Financial Officer & Secretary      
(Principal Financial and Accounting Officer)      

/s/ George J. Isaac

   

May 16, 2011

 
George J. Isaac     Date  
Director      

/s/ William L. Healey

   

May 17, 2011

 
William L. Healey     Date  
Director      

/s/ Michael J. Berthelot

   

May 16, 2011

 
Michael J. Berthelot     Date  
Director      

/s/ David Holder

   

May 18, 2011

 
David Holder     Date  
Director      

 

36